06182024 · Active · incorporated 19 years, 6 months ago · London
Biotech Biotech & Life Sciences Drug Discovery Series B+
A biotechnology company developing inhaled medicines for serious respiratory diseases, including pulmonary aspergillosis.
Pulmocide Limited is a private limited company registered at Companies House under number 06182024, incorporated on 23 March 2007, with a registered office in London. Its current status on the register is active. Its filed nature of business is research and experimental development on biotechnology (SIC 72110). Sonde has indexed 121 filings for this company, including 12 funding rounds. Its most recent round closed in September 2025, raising £23.9m.
| Round | Closed | Raised | Price per share |
|---|---|---|---|
| Round 12 | Sep 2025 | £23.9m | £0.90 |
| Round 11 | Apr 2024 | £42.1m | £0.90 |
| Round 10 | Nov 2022 | £37.4m | £0.90 |
| Round 9 | Nov 2021 | $31.2m | $0.90 |
| Round 8 | May 2021 | £36.8m | £0.90 |
| Round 7 | Jul 2019 | £5m | £1.26 |
Showing the 6 most recent of 12 rounds.
Showing the 10 most recent of 121 filings.
See the complete cap table with every shareholder, founder tags, dilution across 27 share allotments, round-by-round fundraising history, and the full filing timeline — parsed from official Companies House documents.
Create a free account Sign inFree accounts open 3 companies in full detail — no card required.